Roque Pereira, Leonardo http://orcid.org/0000-0002-5878-5088
Durán, Carlos E.
Layton, Deborah
Poulentzas, Georgios
Lalagkas, Panagiotis-Nikolaos
Kontogiorgis, Christos
Sturkenboom, Miriam
Article History
Accepted: 9 February 2022
First Online: 31 March 2022
Change Date: 11 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40264-022-01178-z
Declarations
:
: The ConcePTION project has received funding from the Innovative Medicines Initiative (IMI) 2 Joint Undertaking under grant agreement No 821520. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA.
: Leonardo Roque Pereira is an employee of Roche and Deborah Layton is an employee of IQVIA. Nonetheless, this paper only reflects the personal views of the stated authors. The other authors have no conflicts of interest to declare.
: Not applicable.
: Not applicable.
: Datasets were retrieved from the ENCePP database (EU PAS register) and ClinicalTrials.gov. The assessment of European Summaries of Product Characteristics (SPCs) of corresponding drugs in the Electronic Medicines Compendium (EMC) were retrieved via ExternalRef removed
: Not applicable.
: Not applicable.
: The authors contributed to part of the content and/or the entire content of the manuscript, fulfilling the ICMJE authorship criteria. The Author Declaration forms from each author were uploaded to the DS platform. All authors were invited to add their input to the revised manuscript (to address DRSA comments). All authors read and approved the final version.